4th Quarter - Report

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 2810, S: Medicare Patient Access and Quality Improvement Act of 2013.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2810 (113th)

Health Issues HCR

Promoted life sciences community and communicated economic and health benefits of the industry. Monitored implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013. H.R. 2725: Food and Drug Administration Safety Over Sequestration Act of 2013.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2725 (113th), H.R. 3742 (113th)

Budget/Appropriations BUD

H.J. Res. 59 The Bipartisan Budget Act of 2013 Public Law No: 113-067.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.J.Res. 59 (113th)

Taxation/Internal Revenue Code TAX

H.R. 523: Protect Medical Innovation Act of 2013.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 523 (113th)

Copyright/Patent/Trademark CPT

H.R. 3309: Innovation Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3309 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.